Home > Insider Trading > Filing (0001209191-14-055759)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1415336	Zeltiq Aesthetics Inc	ZLTQ	Electromedical & Electrotherapeutic Apparatus (3845)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1562195	Carl Lamm	4698 Willow Road, Suite 100 Pleasanton CA 94588	Vp Of Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-09-02	284	$1.43	25,008	No	4	M	Direct
Common Stock	Disposition	2014-09-02	284	$21.36	24,724	No	4	S	Direct
Common Stock	Acquisiton	2014-09-02	533	$10.20	25,257	No	4	M	Direct
Common Stock	Disposition	2014-09-02	533	$21.36	24,724	No	4	S	Direct
Common Stock	Acquisiton	2014-09-02	625	$4.30	25,349	No	4	M	Direct
Common Stock	Disposition	2014-09-02	625	$21.36	24,724	No	4	S	Direct
Common Stock	Acquisiton	2014-09-02	365	$11.30	25,089	No	4	M	Direct
Common Stock	Disposition	2014-09-02	365	$21.36	24,724	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-02	284	$0.00	284	$1.43
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-02	533	$0.00	533	$10.20
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-02	625	$0.00	625	$4.30
Common Stock	Stock Option (Right to Buy)	Disposition	2014-09-02	365	$0.00	365	$11.30

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
851	2020-11-29	No	4	M	Direct
5,866	2021-07-26	No	4	M	Direct
16,875	2022-11-14	No	4	M	Direct
6,579	2022-02-16	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the November 26, 2013.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.13 to $21.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
25% of the granted 13,623 shares underlying this option became exercisable on 11/30/2011. The remaining shares vest in a series of 36 equal monthly installments provided that the Reporting Person continues to provide services to the Issuer.
25% of the granted 25,862 shares underlying this option became exercisable on 7/27/2012. The remaining shares vest in a series of 36 equal monthly installments provided that the Reporting Person continues to provide services to the Issuer.
25% of the granted 30,000 shares underlying this option became exercisable on 11/15/2013. The remaining shares vest in a series of 36 equal monthly installments provided that the Reporting Person continues to provide services to the Issuer.
One 48th of the granted 17,544 shares vest in equal monthly installments over a 48 month period from the grant date February 17, 2012, provided that the Reporting Person continues to provide services to the Issuer.